POLICY IMPACT COMMUNICATIONS, INC.

Lobbying for CHROMADEX · Niagen bioscience focusing on the potential of NAD+.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · posted Nov 10, 2025

Lobbying activity 1

Health Issues

Protecting DSHEA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem